tiprankstipranks
Trending News
More News >
Quaker Chemical (KWR)
:KWR
Advertisement

Quaker Chemical (KWR) AI Stock Analysis

Compare
170 Followers

Top Page

KWR

Quaker Chemical

(NYSE:KWR)

Rating:70Neutral
Price Target:
$159.00
▲(9.38% Upside)
Quaker Chemical's stock score is driven by a stable financial position and strong technical momentum, despite profitability challenges and valuation concerns. The earnings call provided a balanced view with positive growth initiatives offset by regional and cost pressures.
Positive Factors
Market Trends
The company's technical sales process has doubled share gains in recent years due to scale advantages and leverage to secular trends like digitalization and automation.
Sales Growth
KWR's leverage to a cyclical recovery could significantly boost EPS, with each 1% of 'surprise' sales growth potentially adding 3.5%-4.2% to EPS.
Valuation
KWR trades at a discount to its quality compounder peers, indicating potential for valuation multiples to improve.
Negative Factors
Market Valuation
Quaker currently trades at ~8.6x NTM EBITDA, 51% below its 5-year and 10-year averages, suggesting potential for valuation improvement.

Quaker Chemical (KWR) vs. SPDR S&P 500 ETF (SPY)

Quaker Chemical Business Overview & Revenue Model

Company DescriptionQuaker Chemical Corporation (KWR) is a global provider of specialty lubricants and coatings, primarily serving the metalworking, automotive, aerospace, and industrial markets. Founded in 1918, the company focuses on delivering high-performance products and innovative solutions that enhance the efficiency and sustainability of manufacturing processes. Quaker Chemical's core offerings include metalworking fluids, rust preventives, and hydraulic fluids, along with a range of applications that support manufacturing operations across various sectors.
How the Company Makes MoneyQuaker Chemical primarily generates revenue through the sale of its specialty lubricants and fluids, which are integral to manufacturing processes in various industries. The company has a diverse revenue model that includes direct sales to customers, as well as distribution through third-party partners. Key revenue streams stem from long-term contracts with major manufacturing firms, which provide a stable income base. Additionally, Quaker Chemical benefits from strategic partnerships and collaborations that enhance its product offerings and market reach. The company also invests in research and development to innovate new products and improve existing ones, which helps maintain a competitive edge and drive sales growth.

Quaker Chemical Earnings Call Summary

Earnings Call Date:Jul 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted positive developments in volume growth, EBITDA improvement, and strategic acquisitions. However, these were tempered by challenges in EMEA, cost pressures from tariffs, and a decline in the Americas segment. While the company is making strides in growth and cost management, ongoing market uncertainties pose risks.
Q2-2025 Updates
Positive Updates
Organic Volume Growth
Quaker Houghton achieved 2% year-over-year organic volume growth, with a notable 8% increase in Asia/Pacific.
Adjusted EBITDA Increase
The company reported $75.5 million of adjusted EBITDA in the second quarter, an increase of approximately $6 million sequentially, with adjusted EBITDA margins of 15.6%.
Share Repurchase and Dividend Increase
Quaker Houghton repurchased $33 million of shares and the Board approved a 5% increase to the cash dividend, marking the 16th consecutive annual increase.
Acquisitions and Integration
The company completed acquisitions of Dipsol and Natech, which are performing in line with expectations, contributing to sales and providing additional market opportunities.
Negative Updates
EMEA Segment Challenges
Persistent market volatility and geopolitical events led to a non-cash goodwill impairment charge in the EMEA segment, impacting overall earnings.
Tariff and Cost Pressures
Uncertainty created by tariffs is impacting demand, product, and geographic mix, along with higher raw material and manufacturing costs.
Americas Segment Decline
Net sales in the Americas declined 1% year-over-year, with a 2% volume decline despite a modest contraction in end markets.
Company Guidance
During the second quarter of 2025, Quaker Houghton demonstrated notable financial performance with a 4% year-over-year increase in sales, driven by a 2% rise in organic sales volume. The company's Asia/Pacific segment led with an 8% increase in organic sales volume, while acquisitions, such as Dipsol, contributed an additional 6% to sales. Despite macroeconomic challenges, Quaker Houghton maintained gross margins at 36%, albeit slightly down from the previous year, influenced by product and geographic mix and higher raw material costs. The company achieved $75.5 million in adjusted EBITDA, reflecting a margin of 15.6%, and generated $42 million in operating cash flow. Quaker Houghton executed a $33 million share repurchase as part of its capital allocation strategy. Looking ahead, the company expects end-market softness to persist but remains confident in achieving its long-term growth targets of 2% to 4% annually through continued business development and strategic cost actions aimed at yielding $20 million in additional savings by the end of 2026.

Quaker Chemical Financial Statement Overview

Summary
Quaker Chemical faces challenges with negative net income and declining revenue growth. However, stable balance sheet metrics and strong operational cash flow provide a buffer against earnings volatility.
Income Statement
65
Positive
The income statement reveals challenges in profitability with a TTM net profit margin of -0.39%, down from a positive 6.34% in the previous year. The gross profit margin is relatively stable at 36.11% for TTM. The revenue growth has declined by 6.18% from 2023 to 2024, indicating a need for revenue generation strategies.
Balance Sheet
70
Positive
The balance sheet shows a moderate debt-to-equity ratio of 0.72 for TTM, a slight increase from the previous year, indicating a manageable but rising leverage. ROE has turned negative at -0.53% for TTM, reflecting recent profitability challenges. The equity ratio remains stable at 47.12%, demonstrating solid equity support.
Cash Flow
75
Positive
Cash flow analysis indicates strong operational efficiency with an operating cash flow to net income ratio of -23.8 for TTM. Free cash flow remains positive, though it declined from 2023 to TTM, suggesting a need to manage capital expenditures.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.83B1.84B1.95B1.94B1.76B1.42B
Gross Profit661.73M686.03M705.64M612.65M594.64M513.44M
EBITDA140.75M194.71M290.11M239.42M253.22M138.74M
Net Income-7.13M116.64M112.75M-17.81M121.37M39.66M
Balance Sheet
Total Assets2.85B2.61B2.71B2.82B2.96B2.89B
Cash, Cash Equivalents and Short-Term Investments201.92M188.88M194.53M180.96M165.18M181.83M
Total Debt960.13M737.82M788.97M979.77M919.68M915.11M
Total Liabilities1.50B1.26B1.33B1.54B1.57B1.57B
Stockholders Equity1.34B1.35B1.38B1.28B1.39B1.32B
Cash Flow
Free Cash Flow152.84M215.86M240.22M13.26M27.48M160.49M
Operating Cash Flow169.57M204.58M279.02M41.79M48.93M178.39M
Investing Cash Flow-223.91M-76.42M-27.62M-40.19M-49.13M-71.39M
Financing Cash Flow64.19M-122.66M-238.61M24.67M-13.46M-75.25M

Quaker Chemical Technical Analysis

Technical Analysis Sentiment
Positive
Last Price145.36
Price Trends
50DMA
125.48
Positive
100DMA
116.01
Positive
200DMA
128.29
Positive
Market Momentum
MACD
6.13
Negative
RSI
72.81
Negative
STOCH
70.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KWR, the sentiment is Positive. The current price of 145.36 is above the 20-day moving average (MA) of 134.26, above the 50-day MA of 125.48, and above the 200-day MA of 128.29, indicating a bullish trend. The MACD of 6.13 indicates Negative momentum. The RSI at 72.81 is Negative, neither overbought nor oversold. The STOCH value of 70.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KWR.

Quaker Chemical Risk Analysis

Quaker Chemical disclosed 30 risk factors in its most recent earnings report. Quaker Chemical reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Quaker Chemical Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Neutral
$2.50B21.71-0.52%1.33%-3.09%-106.46%
68
Neutral
$2.00B1,403.960.13%0.68%-3.93%-97.39%
63
Neutral
$3.15B50.687.06%56.87%
63
Neutral
$2.13B113.971.55%1.86%-5.45%-87.13%
61
Neutral
$10.31B6.290.74%2.95%3.36%-36.41%
57
Neutral
$4.25B11.394.56%2.00%-6.73%
51
Neutral
$2.27B59.33-87.50%4.48%2.48%-459.90%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
KWR
Quaker Chemical
145.36
-20.81
-12.52%
IOSP
Innospec
87.59
-24.52
-21.87%
MTX
Minerals Technologies
65.15
-9.68
-12.94%
SSL
Sasol
6.78
-1.29
-15.99%
CC
Chemours Company
15.07
-3.45
-18.63%
PRM
Perimeter Solutions
22.02
10.58
92.48%

Quaker Chemical Corporate Events

Executive/Board Changes
Quaker Chemical Appoints New Principal Accounting Officer
Neutral
Jul 22, 2025

On July 18, 2025, Jeffrey Kutz resigned as Vice President, Chief Accounting Officer of Quaker Chemical Corporation, with his departure being voluntary and unrelated to any disagreement with the company. Following his resignation, Steve Dassing, who has been with the company since 2022, will assume the role of Principal Accounting Officer while maintaining his position as Vice President, Corporate Controller. The company has updated Mr. Dassing’s salary to $300,000 per annum, and he will continue to participate in the company’s incentive plans. This transition is expected to maintain stability in the company’s financial operations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 23, 2025